01 November 2007
Distribution of TEM and SHV Beta-lactamase genes among Klebsiella pneumoniae strains isolated from patients in Tehran
Fereshteh Shahcheraghi, Haleh Moezi, Mohammad Mehdi FeizabadiMed Sci Monit 2007; 13(11): BR247-250 :: ID: 512825
Abstract
Background: There are numerous types of extended spectrum beta-lactamases (ESBLs), of which TEM and SHV are predominant among Klebsiella pneumoniae strains. Nosocomial infections with strains of K. pneumoniae are common in healthcare centers in Iran. However, no information is available on the prevalence of different phenotypes of ESBL strains in Tehran hospitals.
Material/Methods: To determine the resistance of K. pneumoniae to beta-lactam antibiotics in Tehran hospitals, 145 isolates were tested using the disk diffusion method. The MICs for ceftazidime were also determined using microbroth dilution assay. Isolates showing MIC ≥4 for ceftazidime were subjected to PCR to target the bla[sub]SHV[/sub] and bla[sub]TEM[/sub] genes and screened for ESBL production by the phenotypic confirmatory method.
Results: All strains were susceptible to imipenem. Resistance to ceftazidime and cefotaxime were 31% and 32%, respectively. Fifty-six isolates showed MIC ≥4 µg/ml for ceftazidime, of which 50 were positive for ESBL in the phenotypic confirmatory test. The prevalence of bla[sub]SHV[/sub] and bla[sub]TEM[/sub] among these isolates was 69.6% (n=39) and 32.1% (n=18), respectively. Resistance to ciprofloxacin was found among 32% of the ESBL strains.
Conclusions: SHV is the dominant enzyme among the ESBL-producing strains of Klebsiella pneumoniae in Iran. The high rate of co-resistance to ceftazidime and ciprofloxacin is a matter of concern and treatment requires further attention to the results of susceptibility.
Keywords: Base Sequence, beta-Lactamases - genetics, Polymerase Chain Reaction, Microbial Sensitivity Tests, Klebsiella pneumoniae - isolation & purification, Klebsiella Infections - microbiology, Iran, Genes, Bacterial, Drug Resistance, Bacterial, DNA, Bacterial - genetics, DNA Primers - genetics, Cross Infection - microbiology, Ceftazidime - pharmacology, Cefotaxime - pharmacology, Cefotaxime - pharmacology, beta-Lactamases - genetics, Polymerase Chain Reaction, Microbial Sensitivity Tests, Klebsiella pneumoniae - isolation & purification, Klebsiella Infections - microbiology, Iran, Genes, Bacterial, Drug Resistance, Bacterial, DNA, Bacterial - genetics, DNA Primers - genetics, Cross Infection - microbiology, Ceftazidime - pharmacology, Base Sequence
580 17
Editorial
01 May 2023 : Editorial
Editorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor TherapyDOI: 10.12659/MSM.940911
Med Sci Monit 2023; 29:e940911
In Press
31 May 2023 : Review article
Prevalence, Diagnosis, and Management of Eclampsia and the Need for Improved Maternal Care: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.939919
30 May 2023 : Clinical Research
A Case-Control Study of Cognitive Function in Patients with End-Stage Renal Disease Before and After Hemodi...Med Sci Monit In Press; DOI: 10.12659/MSM.940409
30 May 2023 : Review article
A Review of the Role of the Zebrafish (Danio reiro) in Preclinical and Clinical Models of Biomarker Identif...Med Sci Monit In Press; DOI: 10.12659/MSM.940550
30 May 2023 : Database Analysis
The COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.940904
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952